000			02041nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aPreclinical Evaluation of Lipid-Based Nanosystems
546			_aEnglish[eng]
650			_ananostructured lipid carriers (NLC)||formulation optimization||rivastigmine||quality by design (QbD)||nasal route||nose-to-brain||N-alkylisatin||liposome||urokinase plasminogen activator||PAI-2||SerpinB2||breast cancer||liposomes||target delivery nanosystem||FZD10 protein||colon cancer therapy||supersaturation||silica-lipid hybrid||spray drying||lipolysis||lipid-based formulation||fenofibrate||mesoporous silica||oral drug delivery||hyaluronic acid||drug release||light activation||stability||mobility||biocorona||dissolution enhancement||phospholipids||solid dosage forms||porous microparticles||nanoemulsion(s)||phase-behavior||DoE||D-optimal design||vegetable oils||non-ionic surfactants||efavirenz||flaxseed oil||nanostructured lipid carriers||nanocarrier||docohexaenoic acid||neuroprotection||neuroinflammation||fluconazole||Box‒Behnken design||nanotransfersome||ulcer index||zone of inhibition||rheological behavior||ex vivo permeation||nanomedicine||cancer||doxorubicin||melanoma||drug delivery||ultrasound contrast agents||phospholipid coating||ligand distribution||cholesterol||acoustic response||microbubble||lipid phase||dialysis||ammonia||intoxication||cyanocobalamin||vitamin B12||atopic dermatitis||psoriasis||transferosomes||lipid vesicles||skin topical delivery||oligonucleotide||self-emulsifying drug delivery systems||hydrophobic ion pairing||intestinal permeation enhancers||Caco-2 monolayer||clarithromycin||solid lipid nanoparticles||optimization||permeation||pharmacokinetics||follicular targeting||dexamethasone||alopecia areata||lipomers||lipid polymer hybrid nanocapsules||biodistribution||skin||ethyl cellulose||n/a
700			_aSilva, Ana Catarina||Sousa Lobo, José Manuel
856			_uhttps://mdpi.com/books/pdfview/book/4039
942			_cEB
999			_c35128 _d35128